The effect of melatonin on oxidative stress and apoptosis in experimental diabetes mellitus-related ovarian injury

ArticleAçık Erişim

Özet

We aimed to evaluate the effect of melatonin on oxidative stress and ovarian injury in rats. Twenty-four Sprague-Dawley albino rats were divided into three groups: Group 1 as nondiabetic healthy controls (n = 8), group 2 as nontreated diabetic rats (n = 8) and group 3 as melatonin-treated diabetic rats (n = 8). After overt diabetes was produced by intraperitoneal injection of streptozosin, 20 mg/kg/day of melatonin was given intraperitoneally to group 3 for a week. NF-kB and caspase-3 immunoexpressions, lipid peroxidation, the activities of antioxidative enzymes, total oxidant capacity and total antioxidant capacity were assessed. Immunoexpressions of NF-kB and caspase-3 were significantly lower in group 3 than group 2. There was a significant decrease in superoxide dismutase activity in group 2 than group 1 and a significant increase in group 3 compared with group 2. We observed a nonsignificant decrease in catalase activity between group 1 and group 2 and a nonsignificant increase between group 2 and group 3. There was a nonsignificant increase in the plasma level of total oxidant status in group 2 than group 1, but a significant decrease was observed in group 3 compared to group 2. Total antioxidant status was significantly lower in group 2 compared with group 1 and group 3. In conclusion, melatonin ameliorates the negative effects of oxidative stress on DM-related ovarian injury. © 2015 Taylor & Francis.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14982Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorNayki, Umit
dc.contributor.authorOnk, Didem
dc.contributor.authorBalci, Gurhan
dc.contributor.authorNayki, Cenk
dc.contributor.authorOnk, Alper
dc.contributor.authorÇankaya, Murat
dc.contributor.authorTaskin Kafa, Ayse Humeyra
dc.contributor.authorKuzucu, Mehmet
dc.date.accessioned2026-10-18T20:29:46.875566084Z
dc.date.available2026-10-18T20:29:46.875566084Z
dc.date.issued2016
dc.description.abstractWe aimed to evaluate the effect of melatonin on oxidative stress and ovarian injury in rats. Twenty-four Sprague-Dawley albino rats were divided into three groups: Group 1 as nondiabetic healthy controls (n = 8), group 2 as nontreated diabetic rats (n = 8) and group 3 as melatonin-treated diabetic rats (n = 8). After overt diabetes was produced by intraperitoneal injection of streptozosin, 20 mg/kg/day of melatonin was given intraperitoneally to group 3 for a week. NF-kB and caspase-3 immunoexpressions, lipid peroxidation, the activities of antioxidative enzymes, total oxidant capacity and total antioxidant capacity were assessed. Immunoexpressions of NF-kB and caspase-3 were significantly lower in group 3 than group 2. There was a significant decrease in superoxide dismutase activity in group 2 than group 1 and a significant increase in group 3 compared with group 2. We observed a nonsignificant decrease in catalase activity between group 1 and group 2 and a nonsignificant increase between group 2 and group 3. There was a nonsignificant increase in the plasma level of total oxidant status in group 2 than group 1, but a significant decrease was observed in group 3 compared to group 2. Total antioxidant status was significantly lower in group 2 compared with group 1 and group 3. In conclusion, melatonin ameliorates the negative effects of oxidative stress on DM-related ovarian injury. © 2015 Taylor & Francis.
dc.description.sponsorshipThis study was funded by department of scientific research projects of Erzincan University, Turkey. (Grant number: 96871112-604.02/219-3886)
dc.identifier.doi10.3109/09513590.2015.1126819
dc.identifier.eissn1473-0766
dc.identifier.endpage426
dc.identifier.issn0951-3590
dc.identifier.issue5
dc.identifier.pmid26743008
dc.identifier.scopus2-s2.0-84953739985
dc.identifier.startpage421
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14982
dc.identifier.volume32
dc.identifier.wosWOS:000373897000018
dc.language.isoen
dc.publisherTaylor and Francis Ltd
dc.relation.ispartofGynecological Endocrinology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectApoptosis
dc.subjectdiabetes
dc.subjectNFkB pathway
dc.subjectovary
dc.subjectoxidative stress
dc.subjectrat
dc.subjectAnimals
dc.subjectCaspase 3
dc.subjectDiabetes Mellitus, Experimental
dc.subjectFemale
dc.subjectMelatonin
dc.subjectNF-kappa B
dc.subjectRats
dc.subjectRats, Sprague-Dawley
dc.subjectcatalase
dc.subjectimmunoglobulin enhancer binding protein
dc.subjectmalonaldehyde
dc.subjectsuperoxide dismutase
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectantioxidant activity
dc.subjectArticle
dc.subjectcontrolled study
dc.subjectdiabetes mellitus
dc.subjectdrug effect
dc.subjectenzyme activity
dc.subjectexperimental diabetes mellitus
dc.subjecthistopathology
dc.subjectimmunohistochemistry
dc.titleThe effect of melatonin on oxidative stress and apoptosis in experimental diabetes mellitus-related ovarian injury
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus11
rdl.citation.wos10
rdl.departmente Department of Biochemistry School of Medicine , Erzincan University , Erzincan , Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)